Articles related to NEUROLOGICAL DISORDERS

Prion diseases, while rare, pose significant challenges due to their fatal nature and lack of cure. The recent cases of CJD in hunters highlight the need for ongoing research and surveillance in both human and animal populations.

Recent systematic reviews suggest a subtle increase in NMOSD and MS risks post-COVID-19 vaccination, primarily affecting genetically susceptible individuals.

Manifest Technologies is spearheading the use of AI in developing targeted treatments for CNS disorders, aiming to refine patient selection in clinical trials and enhance therapeutic outcomes.

Physicians should be acutely aware of the heightened risk of neuroinvasive arboviral infections in patients treated with rituximab, necessitating a shift towards molecular diagnostic testing for timely and accurate detection.

Advanced biological aging, as measured by clinical biomarkers, increases one’s risk for dementia or stroke, despite adjustment for disease-specific risk factors. This finding underscores the potential of biological age as a predictor of neurological health.

Healthcare professionals should be aware of the potential for neurological side effects in patients receiving COVID-19 vaccines. With nearly one-third of vaccine recipients experiencing symptoms such as headaches, tremors, and insomnia, continued monitoring and research are crucial.